Similarly, as a novel method for the treatment of glioblastoma multiforme, WJ-MSCs’ exosomes were used to deliver miR-124, which reduced the expression of CDK6 and enhanced chemosensitivity to temozolomide, along with decreasing the migration of glioblastoma multiforme cells (Sharif et al., 2018). Here, CDK6 is linked to glioblastoma.